Oncos Therapeutics
Biotechnology Research • 
Finland • 1-10 Employees
Company overview
| Headquarters | Finland |
| Phone number | +3583552020988 |
| Websites | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
Key Contact at Oncos Therapeutics
Lotta Kangasniemi
Research Director
About Oncos Therapeutics
Oncos Therapeutics develops novel cancer therapies based on its next generation oncolytic viruses. Since the onset of our Advanced Therapy Access Program in 2007, 200 patients have undergone tailored treatment suggesting strong safety and efficacy. The program is based on extensive scientific research at the University of Helsinki and serves as the foundation for our ongoing clinical development.
$
Oncos Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | $5,500,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
United Kingdom
Australia
United States
Canada
Frequently asked questions
Oncos Therapeutics is located in FI.
You can reach Oncos Therapeutics at +3583552020988.
Oncos Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
Oncos Therapeutics has raised a total of $5,500,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.
4.8
40,000 users
